| abstract |
The present invention relates to novel analogs and compositions of glucagon-like peptides useful in up-regulating insulin expression and treating diabetes in mammals. In particular, these peptide analogs have a peptide mimic linker and provide activity associated with long duration of therapeutic activity, gastrointestinal function and glucagon levels in diabetes and other insulinotropic peptide related diseases. |